ReCOVer: A randomized controlled trial testing the efficacy of cognitive behavioural therapy for preventing chronic postinfectious fatigue among patients diagnosed with COVID-19 disease

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.043E+13

Grant search

Key facts

  • Disease

  • Start & end year

  • Known Financial Commitments (USD)

  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principle Investigator

  • Research Location

    Netherlands, Europe
  • Lead Research Institution

    Amsterdam University Medical Center - location AMC
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags


  • Study Subject


  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment


  • Age Group


  • Vulnerable Population


  • Occupations of Interest



Project description Some of the patients who have undergone COVID-19 have complaints. One of those complaints is fatigue. This is often serious and limits people's functioning. Cognitive behavioral therapy can help with severe fatigue that develops during an illness. Behavioral therapy teaches people to deal with complaints differently. Research This project investigates whether behavioral therapy given via the internet also helps with fatigue after COVID-19. By treating faster after the complaint has arisen, it is hoped that the fatigue will not become chronic. There are 114 patients who are hampered by severe fatigue after COVID-19. Half receive behavioral therapy, the other half receive usual care. Coincidence determines which group a participant enters. The treatment lasts four months, with people being examined immediately afterwards and six months after the treatment. Expected outcome By comparing both groups, it is investigated whether behavioral therapy leads to a reduction in fatigue and disability, and whether fewer people become chronically tired after COVID-19.